Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014.

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (Author)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. Government Publishing Office, 2016.
Subjects:	Generic drugs > Labeling > United States. Drugs > Safety regulations > United States. Warning labels > Government policy > United States. Legislative hearings.
Online Access:	https://purl.fdlp.gov/GPO/gpo66684 http://purl.fdlp.gov/GPO/gpo66684

Available Online